Bionano Genomics (BNGO) Amortization of Deferred Charges (2019 - 2021)
Bionano Genomics' (BNGO) quarterly Amortization of Deferred Charges came in at -$205000.0 in Q3 2021, down 168.11% year-on-year from $301000.0 in Q3 2020, and down 401.47% quarter-over-quarter from $68000.0 in Q2 2021.
Bionano Genomics (BNGO) Amortization of Deferred Charges (2019 - 2021) Analysis & Trends
Bionano Genomics has disclosed Amortization of Deferred Charges across 3 years of filings, most recently posting -$205000.0 for Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Bionano Genomics | 14.01 Mn | -366,620.40 | 3.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -205,000.00 |
| Sep 30, 2021 | -205,000.00 |
| Jun 30, 2021 | 68,000.00 |
| Jun 30, 2021 | 68,000.00 |
| Mar 31, 2021 | 315,000.00 |
| Mar 31, 2021 | 315,000.00 |
| Sep 30, 2020 | 301,000.00 |
| Sep 30, 2020 | 301,000.00 |
| Jun 30, 2020 | 272,000.00 |
| Jun 30, 2020 | 272,000.00 |
| Mar 31, 2020 | 379,000.00 |
| Mar 31, 2020 | 379,000.00 |
| Sep 30, 2019 | 227,000.00 |
| Sep 30, 2019 | 227,000.00 |
| Jun 30, 2019 | 247,000.00 |
| Jun 30, 2019 | 247,000.00 |
| Mar 31, 2019 | 49,000.00 |
| Mar 31, 2019 | 49,000.00 |